MoGen

Y Combinator LogoW21ActiveHealth TechArtifical IntelligenceBiotech

Flatiron for Rare Disease

Rare disease treatment has a lot of trial and error due to small numbers of patients. MoGen is solving this by building a database of genetic-treatment-outcome information. Data is collected and aggregated from our patient portal designed to manage complicated conditions and delivered to care providers through our clinician’s portal. We have developed a proprietary AI model to help tailor search results based on genotype.   We plan on expanding from this target space into additional rare genetic disease and contribute to efforts in diagnostics and therapeutics using the data we collect.   Our founding team is stacked with Stanford alumni with PhDs in Genetics, founders with profitable startups and a family member of a rare disease patient.   Here’s a link to my Calendly if you'd like to reach us: https://calendly.com/mogenceo/30min

MoGen
Founded:2020
Team Size:8
Location:Palo Alto

Active Founders

Eesha Sharma

I am co-Founder of an early stage biotech start-up, MoGen. Our company is developing a search engine for rare metabolic disease treatment. These conditions lead to developmental disability if not treated properly. I've been on the patient-family side of this problem. After getting my PhD in Molecular Genetics I thought it was about time to flip the table and do something about it.

Eesha Sharma
Eesha Sharma
MoGen